4 results
Approved WMOCompleted
Primary:To evaluate the effects of FF/UMEC/VI on lung function compared with FF/VI after 24 weeks of treatmentSecondary:To assess the efficacy (exacerbations), FEV1 3h post dose, asthma symptoms, safety and tolerability.
Approved WMOCompleted
Effect on bone mineral density.
Approved WMORecruiting
Primary objective: To assess the safety and efficacy of endovascular renal nerve ablation using the Boston Scientific Vessix V2 renal denervation system in patients with systolic heart failure
Approved WMOCompleted
Primary Objective To evaluate long term safety and tolerability of LAI (590 mg) administered once daily (QD) for up to 12 months in subjects who were refractory to standard multi-drug treatment and failed to convert in Study INS-212. Secondary…